30 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Ericsson (ERIC) Boosts R&D Capabilities With Key Funding https://www.zacks.com/stock/news/2217178/ericsson-eric-boosts-r-d-capabilities-with-key-funding?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2217178 Jan 29, 2024 - The funds are designated to support Ericsson's (ERIC) R&D endeavors from 2023 to 2025 and will play a pivotal role in its commitment to achieving a Net Zero target by 2040.
NextEra Energy (NEE) Q4 Earnings & Revenues Beat Estimates https://www.zacks.com/stock/news/2216056/nextera-energy-nee-q4-earnings-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2216056 Jan 25, 2024 - NextEra Energy (NEE) posts better-than-expected fourth-quarter earnings and revenues. It continues to gain from the thriving Florida economy.
Dominion Energy (D) Stock Declines While Market Improves: Some Information for Investors https://www.zacks.com/stock/news/2215362/dominion-energy-d-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2215362 Jan 24, 2024 - The latest trading day saw Dominion Energy (D) settling at $44.15, representing a -1.45% change from its previous close.
Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363 Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases.
Are Investors Undervaluing D S SMITH (DITHF) Right Now? https://www.zacks.com/stock/news/2205651/are-investors-undervaluing-d-s-smith-dithf-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2205651 Jan 04, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PNM Resources (PNM) to Sell Renewable Joint Venture for $230M https://www.zacks.com/stock/news/2203012/pnm-resources-pnm-to-sell-renewable-joint-venture-for-230m?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2203012 Dec 28, 2023 - PNM Resources (PNM) and American Electric Power inked a deal to divest around 50% stake each in New Mexico Renewable Development, LLC for $230 million.
Is Janus Henderson Research D (JNRFX) a Strong Mutual Fund Pick Right Now? https://www.zacks.com/stock/news/2202040/is-janus-henderson-research-d-jnrfx-a-strong-mutual-fund-pick-right-now?cid=CS-ZC-FT-mutual_fund_equity_report-2202040 Dec 26, 2023 - Mutual Fund Report for JNRFX
Captain D’s signs franchise development agreements in New Jersey and Georgia https://www.nrn.com/fast-casual/captain-d-s-signs-franchise-development-agreements-new-jersey-and-georgia Dec 19, 2023 - New franchisees bring more conversion opportunities to fast casual seafood leader
BioCryst: Factor D Inhibitor Data In 2024 Should Be Watched Closely https://seekingalpha.com/article/4657977-biocryst-factor-d-inhibitor-data-in-2024-should-be-watched-closely?source=feed_all_articles Dec 14, 2023 - BioCryst had $399.2 million in cash as of September 30th 2023; enough cash to fund its operations for at least the next 12 months. Read more here.
Sanofi (SNY) Posts Upbeat Long-Term Outlook, Enhances R&D Focus https://www.zacks.com/stock/news/2195113/sanofi-sny-posts-upbeat-long-term-outlook-enhances-r-d-focus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195113 Dec 07, 2023 - Sanofi (SNY) aims to generate annual sales of over 10 billion euros by 2030, driven by recently launched and potential new products. It intends to enhance R&D focus to become a market leader in immunology.

Pages: 123

<<<Page 3